We are live on ! Find out more
NIM

Northeast Investment Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 25.45%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+25.45%
3 Year Est. Return
+93.39%
5 Year Est. Return
+114.23%
10 Year Est. Return
+466.62%
AUM
$994M
AUM Growth
+$21.1M
Cap. Flow
+$3.98M
Cap. Flow %
0.4%
Top 10 Hldgs %
27.23%
Holding
159
New
6
Increased
56
Reduced
71
Closed
4

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$4.38M
2
SF
Stifel
SF
+$2.76M
3
ABT icon
Abbott
ABT
+$2M
4
NVO
Novo Nordisk
NVO
+$1.91M
5
DIS icon
Walt Disney
DIS
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 17.49%
2 Financials 12.74%
3 Industrials 12.38%
4 Consumer Discretionary 10.08%
5 Technology 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$339B
$15.3M 1.54%
180,422
+3,813
+2% +$313K
NKE icon
27
Nike
NKE
$61.9B
$14.7M 1.48%
266,595
+2,478
+0.9% +$141K
COST icon
28
Costco
COST
$420B
$14.7M 1.47%
93,332
+1,991
+2% +$301K
CLX icon
29
Clorox
CLX
$12.7B
$14.4M 1.45%
104,373
+3,805
+4% +$493K
MCD icon
30
McDonald's
MCD
$195B
$14.3M 1.44%
119,204
+3,575
+3% +$448K
LOW icon
31
Lowe's Companies
LOW
$125B
$14.3M 1.43%
180,146
+5,111
+3% +$395K
NXPI icon
32
NXP Semiconductors
NXPI
$60.4B
$14M 1.41%
179,236
+1,335
+0.8% +$114K
PEP icon
33
PepsiCo
PEP
$190B
$13.5M 1.36%
127,373
-1,503
-1% -$155K
VFC icon
34
VF Corp
VFC
$5.89B
$13.3M 1.34%
229,409
-9,521
-4% -$563K
CELG
35
DELISTED
Celgene Corp
CELG
$12.8M 1.28%
129,318
+2,000
+2% +$207K
NVS icon
36
Novartis
NVS
$297B
$11.6M 1.16%
156,298
-63,393
-29% -$4.38M
UPS icon
37
United Parcel Service
UPS
$88.9B
$11.5M 1.16%
106,642
-400
-0.4% -$41.6K
USB icon
38
US Bancorp
USB
$99.6B
$10.8M 1.09%
268,652
-8,738
-3% -$364K
TMO icon
39
Thermo Fisher Scientific
TMO
$220B
$9.77M 0.98%
66,091
+28,837
+77% +$4.26M
WFC icon
40
Wells Fargo
WFC
$264B
$9.55M 0.96%
201,780
-6,572
-3% -$320K
WY icon
41
Weyerhaeuser
WY
$18.4B
$8.82M 0.89%
296,408
-864
-0.3% -$26.6K
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.32T
$8.81M 0.89%
254,680
-3,280
-1% -$118K
BLK icon
43
Blackrock
BLK
$176B
$8.53M 0.86%
24,912
+1,336
+6% +$469K
GS icon
44
Goldman Sachs
GS
$303B
$8.01M 0.81%
53,912
-1,112
-2% -$174K
SBUX icon
45
Starbucks
SBUX
$120B
$7.46M 0.75%
130,565
+34,076
+35% +$1.94M
MDLZ icon
46
Mondelez International
MDLZ
$79.9B
$7.25M 0.73%
159,393
-5,051
-3% -$220K
FRC
47
DELISTED
First Republic Bank
FRC
$7.19M 0.72%
102,732
+6,476
+7% +$448K
VEU icon
48
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
$6.94M 0.7%
161,873
+1,582
+1% +$68.5K
VEA icon
49
Vanguard FTSE Developed Markets ETF
VEA
$237B
$6.92M 0.7%
195,592
+20,035
+11% +$724K
RTX icon
50
RTX Corp
RTX
$301B
$6.57M 0.66%
101,828
+1,348
+1% +$86.3K

Similar funds

Northeast Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Northeast Investment Management held 159 positions worth $994M, up 2.2% from $973M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Northeast Investment Management's Q2 2016 filing shows 6 new, 56 increased, 71 reduced and 4 closed positions. Its largest new stake was Becton Dickinson: 7,355 shares worth $1.22M. The largest sale was Novartis, an estimated $4.38M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.

  • Northeast Investment Management's largest Q2 2016 buy was Becton Dickinson: 7,355 shares worth $1.22M.
  • Northeast Investment Management added most to Thermo Fisher Scientific in Q2 2016, an estimated $4.26M increase.
  • Northeast Investment Management's biggest Q2 2016 reduction was Novartis, cutting an estimated $4.38M.
  • Northeast Investment Management fully exited Biogen in Q2 2016, selling an estimated $431K.
  • Northeast Investment Management's ten largest holdings make up 27% of its $994M portfolio in Q2 2016.
  • Northeast Investment Management opened 6 new positions and closed 4 in Q2 2016.
  • Northeast Investment Management's portfolio value rose 2.2% quarter-over-quarter to $994M.

Based on Northeast Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.